nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—CYP2D6—Fingolimod—multiple sclerosis	0.069	0.119	CbGbCtD
Sertraline—ABCB1—Methylprednisolone—multiple sclerosis	0.0472	0.0816	CbGbCtD
Sertraline—CYP3A4—Fingolimod—multiple sclerosis	0.0439	0.0758	CbGbCtD
Sertraline—CYP2C19—Prednisone—multiple sclerosis	0.0355	0.0613	CbGbCtD
Sertraline—CYP2B6—Dexamethasone—multiple sclerosis	0.0348	0.0602	CbGbCtD
Sertraline—ABCB1—Mitoxantrone—multiple sclerosis	0.0344	0.0595	CbGbCtD
Sertraline—ABCB1—Betamethasone—multiple sclerosis	0.0307	0.053	CbGbCtD
Sertraline—ABCB1—Prednisolone—multiple sclerosis	0.0303	0.0523	CbGbCtD
Sertraline—ABCB1—Prednisone—multiple sclerosis	0.0286	0.0494	CbGbCtD
Sertraline—CYP3A4—Methylprednisolone—multiple sclerosis	0.0283	0.0489	CbGbCtD
Sertraline—CYP2C19—Dexamethasone—multiple sclerosis	0.0221	0.0382	CbGbCtD
Sertraline—CYP3A4—Triamcinolone—multiple sclerosis	0.0214	0.037	CbGbCtD
Sertraline—CYP3A4—Mitoxantrone—multiple sclerosis	0.0206	0.0357	CbGbCtD
Sertraline—CYP2C9—Dexamethasone—multiple sclerosis	0.0184	0.0318	CbGbCtD
Sertraline—CYP3A4—Betamethasone—multiple sclerosis	0.0184	0.0318	CbGbCtD
Sertraline—CYP3A4—Prednisolone—multiple sclerosis	0.0181	0.0314	CbGbCtD
Sertraline—ABCB1—Dexamethasone—multiple sclerosis	0.0179	0.0309	CbGbCtD
Sertraline—CYP3A4—Prednisone—multiple sclerosis	0.0171	0.0296	CbGbCtD
Sertraline—CYP2D6—Dexamethasone—multiple sclerosis	0.0168	0.0291	CbGbCtD
Sertraline—ABCB1—Methotrexate—multiple sclerosis	0.0144	0.0248	CbGbCtD
Sertraline—CYP3A4—Dexamethasone—multiple sclerosis	0.0107	0.0185	CbGbCtD
Sertraline—SLC6A3—nerve—multiple sclerosis	0.00342	0.0698	CbGeAlD
Sertraline—MAOB—nerve—multiple sclerosis	0.00298	0.0608	CbGeAlD
Sertraline—SLC6A2—nerve—multiple sclerosis	0.00276	0.0563	CbGeAlD
Sertraline—MAOA—nerve—multiple sclerosis	0.00254	0.0519	CbGeAlD
Sertraline—SLC6A3—brainstem—multiple sclerosis	0.00147	0.03	CbGeAlD
Sertraline—SLC6A4—brainstem—multiple sclerosis	0.00134	0.0275	CbGeAlD
Sertraline—MAOB—brainstem—multiple sclerosis	0.00128	0.0261	CbGeAlD
Sertraline—SLC6A2—brainstem—multiple sclerosis	0.00118	0.0242	CbGeAlD
Sertraline—MAOA—brainstem—multiple sclerosis	0.00109	0.0223	CbGeAlD
Sertraline—MAOA—retina—multiple sclerosis	0.00105	0.0215	CbGeAlD
Sertraline—SLC6A3—midbrain—multiple sclerosis	0.000934	0.0191	CbGeAlD
Sertraline—SIGMAR1—medulla oblongata—multiple sclerosis	0.000931	0.019	CbGeAlD
Sertraline—SLC6A3—spinal cord—multiple sclerosis	0.000912	0.0186	CbGeAlD
Sertraline—MAOB—medulla oblongata—multiple sclerosis	0.000891	0.0182	CbGeAlD
Sertraline—SLC6A4—midbrain—multiple sclerosis	0.000856	0.0175	CbGeAlD
Sertraline—SIGMAR1—midbrain—multiple sclerosis	0.00085	0.0174	CbGeAlD
Sertraline—SLC6A4—spinal cord—multiple sclerosis	0.000835	0.0171	CbGeAlD
Sertraline—SIGMAR1—spinal cord—multiple sclerosis	0.00083	0.017	CbGeAlD
Sertraline—SLC6A2—medulla oblongata—multiple sclerosis	0.000825	0.0169	CbGeAlD
Sertraline—MAOB—midbrain—multiple sclerosis	0.000814	0.0166	CbGeAlD
Sertraline—MAOB—spinal cord—multiple sclerosis	0.000794	0.0162	CbGeAlD
Sertraline—SLC6A3—nervous system—multiple sclerosis	0.000768	0.0157	CbGeAlD
Sertraline—MAOA—medulla oblongata—multiple sclerosis	0.00076	0.0155	CbGeAlD
Sertraline—SLC6A3—central nervous system—multiple sclerosis	0.00074	0.0151	CbGeAlD
Sertraline—SLC6A3—cerebellum—multiple sclerosis	0.000723	0.0148	CbGeAlD
Sertraline—SLC6A4—nervous system—multiple sclerosis	0.000704	0.0144	CbGeAlD
Sertraline—MAOA—midbrain—multiple sclerosis	0.000695	0.0142	CbGeAlD
Sertraline—SLC6A4—central nervous system—multiple sclerosis	0.000678	0.0138	CbGeAlD
Sertraline—MAOA—spinal cord—multiple sclerosis	0.000678	0.0138	CbGeAlD
Sertraline—MAOB—nervous system—multiple sclerosis	0.000669	0.0137	CbGeAlD
Sertraline—SIGMAR1—cerebellum—multiple sclerosis	0.000658	0.0134	CbGeAlD
Sertraline—CYP2D6—brainstem—multiple sclerosis	0.000648	0.0132	CbGeAlD
Sertraline—MAOB—central nervous system—multiple sclerosis	0.000644	0.0132	CbGeAlD
Sertraline—MAOB—cerebellum—multiple sclerosis	0.00063	0.0129	CbGeAlD
Sertraline—SLC6A2—nervous system—multiple sclerosis	0.00062	0.0127	CbGeAlD
Sertraline—SLC6A2—central nervous system—multiple sclerosis	0.000597	0.0122	CbGeAlD
Sertraline—SLC6A3—brain—multiple sclerosis	0.000587	0.012	CbGeAlD
Sertraline—MAOA—nervous system—multiple sclerosis	0.000571	0.0117	CbGeAlD
Sertraline—MAOA—central nervous system—multiple sclerosis	0.00055	0.0112	CbGeAlD
Sertraline—SLC6A4—brain—multiple sclerosis	0.000538	0.011	CbGeAlD
Sertraline—MAOA—cerebellum—multiple sclerosis	0.000537	0.011	CbGeAlD
Sertraline—SIGMAR1—brain—multiple sclerosis	0.000534	0.0109	CbGeAlD
Sertraline—MAOB—brain—multiple sclerosis	0.000512	0.0105	CbGeAlD
Sertraline—SLC6A2—brain—multiple sclerosis	0.000474	0.00968	CbGeAlD
Sertraline—CYP2B6—nervous system—multiple sclerosis	0.000457	0.00933	CbGeAlD
Sertraline—ABCB1—retina—multiple sclerosis	0.00045	0.00918	CbGeAlD
Sertraline—CYP2B6—central nervous system—multiple sclerosis	0.00044	0.00898	CbGeAlD
Sertraline—MAOA—brain—multiple sclerosis	0.000436	0.00892	CbGeAlD
Sertraline—CYP2B6—brain—multiple sclerosis	0.000349	0.00713	CbGeAlD
Sertraline—CYP3A4—nervous system—multiple sclerosis	0.000345	0.00705	CbGeAlD
Sertraline—CYP2D6—nervous system—multiple sclerosis	0.000339	0.00693	CbGeAlD
Sertraline—CYP3A4—central nervous system—multiple sclerosis	0.000332	0.00678	CbGeAlD
Sertraline—CYP2D6—central nervous system—multiple sclerosis	0.000327	0.00668	CbGeAlD
Sertraline—ABCB1—medulla oblongata—multiple sclerosis	0.000325	0.00664	CbGeAlD
Sertraline—CYP2D6—cerebellum—multiple sclerosis	0.000319	0.00652	CbGeAlD
Sertraline—ABCB1—midbrain—multiple sclerosis	0.000297	0.00607	CbGeAlD
Sertraline—ABCB1—spinal cord—multiple sclerosis	0.00029	0.00592	CbGeAlD
Sertraline—CYP2D6—brain—multiple sclerosis	0.000259	0.0053	CbGeAlD
Sertraline—ABCB1—nervous system—multiple sclerosis	0.000244	0.00499	CbGeAlD
Sertraline—ABCB1—central nervous system—multiple sclerosis	0.000235	0.0048	CbGeAlD
Sertraline—ABCB1—cerebellum—multiple sclerosis	0.00023	0.00469	CbGeAlD
Sertraline—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.000208	0.0041	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000206	0.00404	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000206	0.00404	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000204	0.00402	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000199	0.0039	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000199	0.0039	CbGpPWpGaD
Sertraline—SLC6A3—Monoamine Transport—IL1B—multiple sclerosis	0.000198	0.00389	CbGpPWpGaD
Sertraline—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000197	0.00388	CbGpPWpGaD
Sertraline—SLC6A4—Monoamine Transport—TNF—multiple sclerosis	0.000189	0.00371	CbGpPWpGaD
Sertraline—ABCB1—brain—multiple sclerosis	0.000187	0.00381	CbGeAlD
Sertraline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000184	0.00361	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000181	0.00356	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000181	0.00355	CbGpPWpGaD
Sertraline—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000178	0.0035	CbGpPWpGaD
Sertraline—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000178	0.0035	CbGpPWpGaD
Sertraline—SLC6A3—Dopaminergic Neurogenesis—STAT3—multiple sclerosis	0.000175	0.00344	CbGpPWpGaD
Sertraline—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000172	0.00338	CbGpPWpGaD
Sertraline—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000171	0.00337	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.00017	0.00335	CbGpPWpGaD
Sertraline—SLC6A2—Monoamine Transport—TNF—multiple sclerosis	0.000162	0.00319	CbGpPWpGaD
Sertraline—SLC6A3—Dopaminergic Neurogenesis—TGFB1—multiple sclerosis	0.000162	0.00319	CbGpPWpGaD
Sertraline—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000159	0.000495	CcSEcCtD
Sertraline—Paraesthesia—Prednisolone—multiple sclerosis	0.000159	0.000495	CcSEcCtD
Sertraline—Tachycardia—Triamcinolone—multiple sclerosis	0.000159	0.000495	CcSEcCtD
Sertraline—Mental disorder—Prednisone—multiple sclerosis	0.000159	0.000494	CcSEcCtD
Sertraline—Nausea—Azathioprine—multiple sclerosis	0.000159	0.000493	CcSEcCtD
Sertraline—Tachycardia—Methylprednisolone—multiple sclerosis	0.000159	0.000493	CcSEcCtD
Sertraline—Skin disorder—Methylprednisolone—multiple sclerosis	0.000158	0.000491	CcSEcCtD
Sertraline—Erythema—Prednisone—multiple sclerosis	0.000158	0.000491	CcSEcCtD
Sertraline—Malnutrition—Prednisone—multiple sclerosis	0.000158	0.000491	CcSEcCtD
Sertraline—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000158	0.0031	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000157	0.00309	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000157	0.00309	CbGpPWpGaD
Sertraline—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000157	0.00049	CcSEcCtD
Sertraline—Agranulocytosis—Methotrexate—multiple sclerosis	0.000157	0.00049	CcSEcCtD
Sertraline—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000157	0.000489	CcSEcCtD
Sertraline—Convulsion—Dexamethasone—multiple sclerosis	0.000157	0.000488	CcSEcCtD
Sertraline—Convulsion—Betamethasone—multiple sclerosis	0.000157	0.000488	CcSEcCtD
Sertraline—Hypertension—Betamethasone—multiple sclerosis	0.000156	0.000486	CcSEcCtD
Sertraline—Hypertension—Dexamethasone—multiple sclerosis	0.000156	0.000486	CcSEcCtD
Sertraline—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000155	0.00305	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000155	0.00305	CbGpPWpGaD
Sertraline—Asthenia—Mitoxantrone—multiple sclerosis	0.000155	0.000482	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000155	0.00304	CbGpPWpGaD
Sertraline—Myalgia—Betamethasone—multiple sclerosis	0.000154	0.00048	CcSEcCtD
Sertraline—Myalgia—Dexamethasone—multiple sclerosis	0.000154	0.00048	CcSEcCtD
Sertraline—Anxiety—Betamethasone—multiple sclerosis	0.000154	0.000478	CcSEcCtD
Sertraline—Anxiety—Dexamethasone—multiple sclerosis	0.000154	0.000478	CcSEcCtD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000153	0.00301	CbGpPWpGaD
Sertraline—Discomfort—Betamethasone—multiple sclerosis	0.000152	0.000474	CcSEcCtD
Sertraline—Discomfort—Dexamethasone—multiple sclerosis	0.000152	0.000474	CcSEcCtD
Sertraline—Haemoglobin—Methotrexate—multiple sclerosis	0.000152	0.000473	CcSEcCtD
Sertraline—Hypotension—Methylprednisolone—multiple sclerosis	0.000152	0.000472	CcSEcCtD
Sertraline—Pain—Prednisolone—multiple sclerosis	0.000151	0.000471	CcSEcCtD
Sertraline—Haemorrhage—Methotrexate—multiple sclerosis	0.000151	0.000471	CcSEcCtD
Sertraline—Hepatitis—Methotrexate—multiple sclerosis	0.000151	0.000471	CcSEcCtD
Sertraline—Pharyngitis—Methotrexate—multiple sclerosis	0.00015	0.000467	CcSEcCtD
Sertraline—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000149	0.000465	CcSEcCtD
Sertraline—Urethral disorder—Methotrexate—multiple sclerosis	0.000148	0.000462	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000148	0.000462	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000148	0.000461	CcSEcCtD
Sertraline—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000148	0.00046	CcSEcCtD
Sertraline—Oedema—Dexamethasone—multiple sclerosis	0.000148	0.00046	CcSEcCtD
Sertraline—Oedema—Betamethasone—multiple sclerosis	0.000148	0.00046	CcSEcCtD
Sertraline—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000148	0.00046	CcSEcCtD
Sertraline—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000148	0.000459	CcSEcCtD
Sertraline—Insomnia—Triamcinolone—multiple sclerosis	0.000147	0.000458	CcSEcCtD
Sertraline—Insomnia—Methylprednisolone—multiple sclerosis	0.000147	0.000457	CcSEcCtD
Sertraline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000147	0.00289	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000146	0.00288	CbGpPWpGaD
Sertraline—Ill-defined disorder—Prednisone—multiple sclerosis	0.000146	0.000455	CcSEcCtD
Sertraline—Paraesthesia—Triamcinolone—multiple sclerosis	0.000146	0.000455	CcSEcCtD
Sertraline—Feeling abnormal—Prednisolone—multiple sclerosis	0.000146	0.000454	CcSEcCtD
Sertraline—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000146	0.000454	CcSEcCtD
Sertraline—Visual impairment—Methotrexate—multiple sclerosis	0.000146	0.000454	CcSEcCtD
Sertraline—Anaemia—Prednisone—multiple sclerosis	0.000146	0.000453	CcSEcCtD
Sertraline—Shock—Dexamethasone—multiple sclerosis	0.000145	0.000452	CcSEcCtD
Sertraline—Shock—Betamethasone—multiple sclerosis	0.000145	0.000452	CcSEcCtD
Sertraline—Dyspnoea—Triamcinolone—multiple sclerosis	0.000145	0.000452	CcSEcCtD
Sertraline—Nervous system disorder—Betamethasone—multiple sclerosis	0.000145	0.000451	CcSEcCtD
Sertraline—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000145	0.000451	CcSEcCtD
Sertraline—Agitation—Prednisone—multiple sclerosis	0.000145	0.000451	CcSEcCtD
Sertraline—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000145	0.00285	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000145	0.00285	CbGpPWpGaD
Sertraline—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000145	0.00045	CcSEcCtD
Sertraline—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000145	0.00045	CcSEcCtD
Sertraline—Tachycardia—Dexamethasone—multiple sclerosis	0.000144	0.000449	CcSEcCtD
Sertraline—Tachycardia—Betamethasone—multiple sclerosis	0.000144	0.000449	CcSEcCtD
Sertraline—Angioedema—Prednisone—multiple sclerosis	0.000144	0.000448	CcSEcCtD
Sertraline—SLC6A3—Monoamine Transport—TNF—multiple sclerosis	0.000144	0.00283	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000144	0.00282	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000144	0.00282	CbGpPWpGaD
Sertraline—Dyspepsia—Triamcinolone—multiple sclerosis	0.000143	0.000446	CcSEcCtD
Sertraline—Erythema multiforme—Methotrexate—multiple sclerosis	0.000143	0.000445	CcSEcCtD
Sertraline—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000143	0.000445	CcSEcCtD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000143	0.00281	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000143	0.00281	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000143	0.00281	CbGpPWpGaD
Sertraline—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000143	0.000444	CcSEcCtD
Sertraline—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000143	0.000444	CcSEcCtD
Sertraline—Malaise—Prednisone—multiple sclerosis	0.000142	0.000442	CcSEcCtD
Sertraline—Vertigo—Prednisone—multiple sclerosis	0.000142	0.000441	CcSEcCtD
Sertraline—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000142	0.00278	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000142	0.00278	CbGpPWpGaD
Sertraline—Eye disorder—Methotrexate—multiple sclerosis	0.000141	0.00044	CcSEcCtD
Sertraline—Syncope—Prednisone—multiple sclerosis	0.000141	0.00044	CcSEcCtD
Sertraline—Tinnitus—Methotrexate—multiple sclerosis	0.000141	0.000439	CcSEcCtD
Sertraline—MAOA—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000141	0.00277	CbGpPWpGaD
Sertraline—Anorexia—Dexamethasone—multiple sclerosis	0.000141	0.000438	CcSEcCtD
Sertraline—Anorexia—Betamethasone—multiple sclerosis	0.000141	0.000438	CcSEcCtD
Sertraline—Urticaria—Prednisolone—multiple sclerosis	0.000141	0.000438	CcSEcCtD
Sertraline—Cardiac disorder—Methotrexate—multiple sclerosis	0.00014	0.000437	CcSEcCtD
Sertraline—Fatigue—Triamcinolone—multiple sclerosis	0.00014	0.000437	CcSEcCtD
Sertraline—Fatigue—Methylprednisolone—multiple sclerosis	0.00014	0.000436	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.00014	0.00274	CbGpPWpGaD
Sertraline—Pain—Triamcinolone—multiple sclerosis	0.000139	0.000433	CcSEcCtD
Sertraline—Loss of consciousness—Prednisone—multiple sclerosis	0.000139	0.000431	CcSEcCtD
Sertraline—Hypotension—Dexamethasone—multiple sclerosis	0.000138	0.00043	CcSEcCtD
Sertraline—Hypotension—Betamethasone—multiple sclerosis	0.000138	0.00043	CcSEcCtD
Sertraline—Angiopathy—Methotrexate—multiple sclerosis	0.000137	0.000427	CcSEcCtD
Sertraline—Vomiting—Mitoxantrone—multiple sclerosis	0.000137	0.000427	CcSEcCtD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000137	0.00269	CbGpPWpGaD
Sertraline—Immune system disorder—Methotrexate—multiple sclerosis	0.000137	0.000425	CcSEcCtD
Sertraline—Convulsion—Prednisone—multiple sclerosis	0.000137	0.000425	CcSEcCtD
Sertraline—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000136	0.000424	CcSEcCtD
Sertraline—Hypertension—Prednisone—multiple sclerosis	0.000136	0.000424	CcSEcCtD
Sertraline—Rash—Mitoxantrone—multiple sclerosis	0.000136	0.000423	CcSEcCtD
Sertraline—Dermatitis—Mitoxantrone—multiple sclerosis	0.000136	0.000423	CcSEcCtD
Sertraline—Chills—Methotrexate—multiple sclerosis	0.000136	0.000423	CcSEcCtD
Sertraline—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000136	0.00266	CbGpPWpGaD
Sertraline—Headache—Mitoxantrone—multiple sclerosis	0.000135	0.000421	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000135	0.000419	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000135	0.000419	CcSEcCtD
Sertraline—Myalgia—Prednisone—multiple sclerosis	0.000134	0.000418	CcSEcCtD
Sertraline—Arthralgia—Prednisone—multiple sclerosis	0.000134	0.000418	CcSEcCtD
Sertraline—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000134	0.000418	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000134	0.00264	CbGpPWpGaD
Sertraline—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000134	0.000417	CcSEcCtD
Sertraline—Anxiety—Prednisone—multiple sclerosis	0.000134	0.000416	CcSEcCtD
Sertraline—Alopecia—Methotrexate—multiple sclerosis	0.000134	0.000416	CcSEcCtD
Sertraline—Insomnia—Dexamethasone—multiple sclerosis	0.000134	0.000416	CcSEcCtD
Sertraline—Insomnia—Betamethasone—multiple sclerosis	0.000134	0.000416	CcSEcCtD
Sertraline—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000133	0.00262	CbGpPWpGaD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000133	0.000415	CcSEcCtD
Sertraline—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000133	0.000413	CcSEcCtD
Sertraline—Paraesthesia—Dexamethasone—multiple sclerosis	0.000133	0.000413	CcSEcCtD
Sertraline—Paraesthesia—Betamethasone—multiple sclerosis	0.000133	0.000413	CcSEcCtD
Sertraline—Discomfort—Prednisone—multiple sclerosis	0.000133	0.000413	CcSEcCtD
Sertraline—Mental disorder—Methotrexate—multiple sclerosis	0.000133	0.000413	CcSEcCtD
Sertraline—Erythema—Methotrexate—multiple sclerosis	0.000132	0.00041	CcSEcCtD
Sertraline—Malnutrition—Methotrexate—multiple sclerosis	0.000132	0.00041	CcSEcCtD
Sertraline—Hypersensitivity—Prednisolone—multiple sclerosis	0.00013	0.000406	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.00013	0.00256	CbGpPWpGaD
Sertraline—Dyspepsia—Dexamethasone—multiple sclerosis	0.00013	0.000405	CcSEcCtD
Sertraline—Dyspepsia—Betamethasone—multiple sclerosis	0.00013	0.000405	CcSEcCtD
Sertraline—Urticaria—Triamcinolone—multiple sclerosis	0.000129	0.000403	CcSEcCtD
Sertraline—Urticaria—Methylprednisolone—multiple sclerosis	0.000129	0.000402	CcSEcCtD
Sertraline—Dysgeusia—Methotrexate—multiple sclerosis	0.000129	0.000401	CcSEcCtD
Sertraline—Body temperature increased—Triamcinolone—multiple sclerosis	0.000129	0.000401	CcSEcCtD
Sertraline—MAOB—Metabolism—SRM—multiple sclerosis	0.000129	0.00253	CbGpPWpGaD
Sertraline—Oedema—Prednisone—multiple sclerosis	0.000129	0.0004	CcSEcCtD
Sertraline—Anaphylactic shock—Prednisone—multiple sclerosis	0.000129	0.0004	CcSEcCtD
Sertraline—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000128	0.0004	CcSEcCtD
Sertraline—Decreased appetite—Dexamethasone—multiple sclerosis	0.000128	0.0004	CcSEcCtD
Sertraline—Decreased appetite—Betamethasone—multiple sclerosis	0.000128	0.0004	CcSEcCtD
Sertraline—MAOA—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000128	0.00252	CbGpPWpGaD
Sertraline—Nausea—Mitoxantrone—multiple sclerosis	0.000128	0.000399	CcSEcCtD
Sertraline—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000128	0.000397	CcSEcCtD
Sertraline—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000128	0.000397	CcSEcCtD
Sertraline—Back pain—Methotrexate—multiple sclerosis	0.000127	0.000397	CcSEcCtD
Sertraline—Fatigue—Dexamethasone—multiple sclerosis	0.000127	0.000396	CcSEcCtD
Sertraline—Fatigue—Betamethasone—multiple sclerosis	0.000127	0.000396	CcSEcCtD
Sertraline—Shock—Prednisone—multiple sclerosis	0.000127	0.000394	CcSEcCtD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000127	0.00249	CbGpPWpGaD
Sertraline—Pain—Betamethasone—multiple sclerosis	0.000126	0.000393	CcSEcCtD
Sertraline—Pain—Dexamethasone—multiple sclerosis	0.000126	0.000393	CcSEcCtD
Sertraline—Nervous system disorder—Prednisone—multiple sclerosis	0.000126	0.000393	CcSEcCtD
Sertraline—Tachycardia—Prednisone—multiple sclerosis	0.000126	0.000391	CcSEcCtD
Sertraline—Skin disorder—Prednisone—multiple sclerosis	0.000125	0.000389	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000125	0.00245	CbGpPWpGaD
Sertraline—Hyperhidrosis—Prednisone—multiple sclerosis	0.000124	0.000387	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000124	0.00243	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000123	0.00241	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000123	0.00241	CbGpPWpGaD
Sertraline—Anorexia—Prednisone—multiple sclerosis	0.000123	0.000382	CcSEcCtD
Sertraline—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000122	0.00038	CcSEcCtD
Sertraline—Anaemia—Methotrexate—multiple sclerosis	0.000122	0.000379	CcSEcCtD
Sertraline—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000122	0.000379	CcSEcCtD
Sertraline—Feeling abnormal—Betamethasone—multiple sclerosis	0.000122	0.000379	CcSEcCtD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000121	0.00239	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000121	0.00238	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000121	0.00238	CbGpPWpGaD
Sertraline—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000121	0.000376	CcSEcCtD
Sertraline—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000121	0.000376	CcSEcCtD
Sertraline—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00012	0.000373	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.00012	0.00236	CbGpPWpGaD
Sertraline—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00012	0.000372	CcSEcCtD
Sertraline—SLC6A3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000119	0.00234	CbGpPWpGaD
Sertraline—MAOB—Biological oxidations—POMC—multiple sclerosis	0.000119	0.00234	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000119	0.00234	CbGpPWpGaD
Sertraline—Malaise—Methotrexate—multiple sclerosis	0.000119	0.00037	CcSEcCtD
Sertraline—Vertigo—Methotrexate—multiple sclerosis	0.000118	0.000368	CcSEcCtD
Sertraline—Leukopenia—Methotrexate—multiple sclerosis	0.000118	0.000367	CcSEcCtD
Sertraline—Urticaria—Dexamethasone—multiple sclerosis	0.000117	0.000365	CcSEcCtD
Sertraline—Urticaria—Betamethasone—multiple sclerosis	0.000117	0.000365	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000117	0.000365	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000117	0.0023	CbGpPWpGaD
Sertraline—Dizziness—Prednisolone—multiple sclerosis	0.000117	0.000364	CcSEcCtD
Sertraline—Asthenia—Triamcinolone—multiple sclerosis	0.000117	0.000364	CcSEcCtD
Sertraline—Body temperature increased—Betamethasone—multiple sclerosis	0.000117	0.000363	CcSEcCtD
Sertraline—Body temperature increased—Dexamethasone—multiple sclerosis	0.000117	0.000363	CcSEcCtD
Sertraline—Abdominal pain—Dexamethasone—multiple sclerosis	0.000117	0.000363	CcSEcCtD
Sertraline—Abdominal pain—Betamethasone—multiple sclerosis	0.000117	0.000363	CcSEcCtD
Sertraline—Asthenia—Methylprednisolone—multiple sclerosis	0.000117	0.000363	CcSEcCtD
Sertraline—Insomnia—Prednisone—multiple sclerosis	0.000116	0.000362	CcSEcCtD
Sertraline—Paraesthesia—Prednisone—multiple sclerosis	0.000116	0.00036	CcSEcCtD
Sertraline—Pruritus—Triamcinolone—multiple sclerosis	0.000115	0.000358	CcSEcCtD
Sertraline—Cough—Methotrexate—multiple sclerosis	0.000115	0.000358	CcSEcCtD
Sertraline—Pruritus—Methylprednisolone—multiple sclerosis	0.000115	0.000358	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000114	0.00225	CbGpPWpGaD
Sertraline—Convulsion—Methotrexate—multiple sclerosis	0.000114	0.000355	CcSEcCtD
Sertraline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000113	0.00223	CbGpPWpGaD
Sertraline—Dyspepsia—Prednisone—multiple sclerosis	0.000113	0.000352	CcSEcCtD
Sertraline—Arthralgia—Methotrexate—multiple sclerosis	0.000112	0.000349	CcSEcCtD
Sertraline—Chest pain—Methotrexate—multiple sclerosis	0.000112	0.000349	CcSEcCtD
Sertraline—Myalgia—Methotrexate—multiple sclerosis	0.000112	0.000349	CcSEcCtD
Sertraline—Decreased appetite—Prednisone—multiple sclerosis	0.000112	0.000348	CcSEcCtD
Sertraline—Rash—Prednisolone—multiple sclerosis	0.000112	0.000347	CcSEcCtD
Sertraline—Dermatitis—Prednisolone—multiple sclerosis	0.000112	0.000347	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000111	0.000347	CcSEcCtD
Sertraline—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000111	0.000346	CcSEcCtD
Sertraline—Fatigue—Prednisone—multiple sclerosis	0.000111	0.000345	CcSEcCtD
Sertraline—Headache—Prednisolone—multiple sclerosis	0.000111	0.000345	CcSEcCtD
Sertraline—Discomfort—Methotrexate—multiple sclerosis	0.000111	0.000345	CcSEcCtD
Sertraline—Constipation—Prednisone—multiple sclerosis	0.00011	0.000342	CcSEcCtD
Sertraline—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000109	0.00214	CbGpPWpGaD
Sertraline—Confusional state—Methotrexate—multiple sclerosis	0.000108	0.000337	CcSEcCtD
Sertraline—Dizziness—Triamcinolone—multiple sclerosis	0.000108	0.000335	CcSEcCtD
Sertraline—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000108	0.000335	CcSEcCtD
Sertraline—Dizziness—Methylprednisolone—multiple sclerosis	0.000107	0.000334	CcSEcCtD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000107	0.0021	CbGpPWpGaD
Sertraline—Feeling abnormal—Prednisone—multiple sclerosis	0.000106	0.00033	CcSEcCtD
Sertraline—Asthenia—Betamethasone—multiple sclerosis	0.000106	0.00033	CcSEcCtD
Sertraline—Asthenia—Dexamethasone—multiple sclerosis	0.000106	0.00033	CcSEcCtD
Sertraline—Nervous system disorder—Methotrexate—multiple sclerosis	0.000105	0.000328	CcSEcCtD
Sertraline—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000105	0.000328	CcSEcCtD
Sertraline—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000105	0.000327	CcSEcCtD
Sertraline—Nausea—Prednisolone—multiple sclerosis	0.000105	0.000327	CcSEcCtD
Sertraline—Pruritus—Dexamethasone—multiple sclerosis	0.000105	0.000325	CcSEcCtD
Sertraline—Pruritus—Betamethasone—multiple sclerosis	0.000105	0.000325	CcSEcCtD
Sertraline—Skin disorder—Methotrexate—multiple sclerosis	0.000104	0.000325	CcSEcCtD
Sertraline—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000104	0.000323	CcSEcCtD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000104	0.00204	CbGpPWpGaD
Sertraline—Vomiting—Triamcinolone—multiple sclerosis	0.000104	0.000322	CcSEcCtD
Sertraline—Vomiting—Methylprednisolone—multiple sclerosis	0.000103	0.000321	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000103	0.00203	CbGpPWpGaD
Sertraline—Rash—Triamcinolone—multiple sclerosis	0.000103	0.000319	CcSEcCtD
Sertraline—Dermatitis—Triamcinolone—multiple sclerosis	0.000103	0.000319	CcSEcCtD
Sertraline—Anorexia—Methotrexate—multiple sclerosis	0.000103	0.000319	CcSEcCtD
Sertraline—Rash—Methylprednisolone—multiple sclerosis	0.000102	0.000319	CcSEcCtD
Sertraline—Dermatitis—Methylprednisolone—multiple sclerosis	0.000102	0.000318	CcSEcCtD
Sertraline—SLC6A4—Circadian rythm related genes—FAS—multiple sclerosis	0.000102	0.00201	CbGpPWpGaD
Sertraline—Urticaria—Prednisone—multiple sclerosis	0.000102	0.000318	CcSEcCtD
Sertraline—Headache—Triamcinolone—multiple sclerosis	0.000102	0.000317	CcSEcCtD
Sertraline—Headache—Methylprednisolone—multiple sclerosis	0.000102	0.000317	CcSEcCtD
Sertraline—Abdominal pain—Prednisone—multiple sclerosis	0.000102	0.000316	CcSEcCtD
Sertraline—Body temperature increased—Prednisone—multiple sclerosis	0.000102	0.000316	CcSEcCtD
Sertraline—Diarrhoea—Dexamethasone—multiple sclerosis	0.000101	0.000315	CcSEcCtD
Sertraline—Diarrhoea—Betamethasone—multiple sclerosis	0.000101	0.000315	CcSEcCtD
Sertraline—Hypotension—Methotrexate—multiple sclerosis	0.0001	0.000313	CcSEcCtD
Sertraline—MAOA—Neuronal System—BCHE—multiple sclerosis	9.83e-05	0.00193	CbGpPWpGaD
Sertraline—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	9.8e-05	0.000305	CcSEcCtD
Sertraline—Dizziness—Dexamethasone—multiple sclerosis	9.77e-05	0.000304	CcSEcCtD
Sertraline—Dizziness—Betamethasone—multiple sclerosis	9.77e-05	0.000304	CcSEcCtD
Sertraline—Insomnia—Methotrexate—multiple sclerosis	9.73e-05	0.000303	CcSEcCtD
Sertraline—Nausea—Triamcinolone—multiple sclerosis	9.67e-05	0.000301	CcSEcCtD
Sertraline—Paraesthesia—Methotrexate—multiple sclerosis	9.66e-05	0.0003	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	9.65e-05	0.0019	CbGpPWpGaD
Sertraline—Nausea—Methylprednisolone—multiple sclerosis	9.65e-05	0.0003	CcSEcCtD
Sertraline—Dyspnoea—Methotrexate—multiple sclerosis	9.59e-05	0.000298	CcSEcCtD
Sertraline—Somnolence—Methotrexate—multiple sclerosis	9.56e-05	0.000297	CcSEcCtD
Sertraline—Hypersensitivity—Prednisone—multiple sclerosis	9.48e-05	0.000295	CcSEcCtD
Sertraline—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	9.47e-05	0.00186	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	9.47e-05	0.00186	CbGpPWpGaD
Sertraline—Dyspepsia—Methotrexate—multiple sclerosis	9.47e-05	0.000295	CcSEcCtD
Sertraline—Vomiting—Dexamethasone—multiple sclerosis	9.39e-05	0.000292	CcSEcCtD
Sertraline—Vomiting—Betamethasone—multiple sclerosis	9.39e-05	0.000292	CcSEcCtD
Sertraline—Decreased appetite—Methotrexate—multiple sclerosis	9.35e-05	0.000291	CcSEcCtD
Sertraline—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.34e-05	0.00184	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.34e-05	0.00184	CbGpPWpGaD
Sertraline—Rash—Betamethasone—multiple sclerosis	9.32e-05	0.00029	CcSEcCtD
Sertraline—Rash—Dexamethasone—multiple sclerosis	9.32e-05	0.00029	CcSEcCtD
Sertraline—Dermatitis—Betamethasone—multiple sclerosis	9.31e-05	0.00029	CcSEcCtD
Sertraline—Dermatitis—Dexamethasone—multiple sclerosis	9.31e-05	0.00029	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—CD86—multiple sclerosis	9.3e-05	0.00183	CbGpPWpGaD
Sertraline—Gastrointestinal disorder—Methotrexate—multiple sclerosis	9.28e-05	0.000289	CcSEcCtD
Sertraline—Fatigue—Methotrexate—multiple sclerosis	9.27e-05	0.000288	CcSEcCtD
Sertraline—Headache—Dexamethasone—multiple sclerosis	9.26e-05	0.000288	CcSEcCtD
Sertraline—Headache—Betamethasone—multiple sclerosis	9.26e-05	0.000288	CcSEcCtD
Sertraline—Asthenia—Prednisone—multiple sclerosis	9.23e-05	0.000287	CcSEcCtD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.2e-05	0.00181	CbGpPWpGaD
Sertraline—Pain—Methotrexate—multiple sclerosis	9.2e-05	0.000286	CcSEcCtD
Sertraline—SLC6A3—Neuronal System—BCHE—multiple sclerosis	9.14e-05	0.0018	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	9.12e-05	0.00179	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL10—multiple sclerosis	9.12e-05	0.00179	CbGpPWpGaD
Sertraline—Pruritus—Prednisone—multiple sclerosis	9.1e-05	0.000283	CcSEcCtD
Sertraline—MAOB—Metabolism—CYP24A1—multiple sclerosis	9.07e-05	0.00178	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CYP27B1—multiple sclerosis	9.07e-05	0.00178	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL4—multiple sclerosis	8.87e-05	0.00174	CbGpPWpGaD
Sertraline—Feeling abnormal—Methotrexate—multiple sclerosis	8.86e-05	0.000276	CcSEcCtD
Sertraline—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.82e-05	0.00173	CbGpPWpGaD
Sertraline—Diarrhoea—Prednisone—multiple sclerosis	8.8e-05	0.000274	CcSEcCtD
Sertraline—Gastrointestinal pain—Methotrexate—multiple sclerosis	8.79e-05	0.000274	CcSEcCtD
Sertraline—Nausea—Betamethasone—multiple sclerosis	8.78e-05	0.000273	CcSEcCtD
Sertraline—Nausea—Dexamethasone—multiple sclerosis	8.78e-05	0.000273	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	8.67e-05	0.0017	CbGpPWpGaD
Sertraline—Urticaria—Methotrexate—multiple sclerosis	8.54e-05	0.000266	CcSEcCtD
Sertraline—Dizziness—Prednisone—multiple sclerosis	8.51e-05	0.000265	CcSEcCtD
Sertraline—Body temperature increased—Methotrexate—multiple sclerosis	8.5e-05	0.000265	CcSEcCtD
Sertraline—Abdominal pain—Methotrexate—multiple sclerosis	8.5e-05	0.000265	CcSEcCtD
Sertraline—MAOB—Metabolism—GPC5—multiple sclerosis	8.29e-05	0.00163	CbGpPWpGaD
Sertraline—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.23e-05	0.00162	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.21e-05	0.00161	CbGpPWpGaD
Sertraline—Vomiting—Prednisone—multiple sclerosis	8.18e-05	0.000255	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—FAS—multiple sclerosis	8.17e-05	0.00161	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	8.12e-05	0.0016	CbGpPWpGaD
Sertraline—Rash—Prednisone—multiple sclerosis	8.11e-05	0.000252	CcSEcCtD
Sertraline—Dermatitis—Prednisone—multiple sclerosis	8.11e-05	0.000252	CcSEcCtD
Sertraline—MAOA—Metabolism—SRM—multiple sclerosis	8.08e-05	0.00159	CbGpPWpGaD
Sertraline—Headache—Prednisone—multiple sclerosis	8.06e-05	0.000251	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	8.03e-05	0.00158	CbGpPWpGaD
Sertraline—Hypersensitivity—Methotrexate—multiple sclerosis	7.92e-05	0.000247	CcSEcCtD
Sertraline—Asthenia—Methotrexate—multiple sclerosis	7.72e-05	0.00024	CcSEcCtD
Sertraline—Nausea—Prednisone—multiple sclerosis	7.64e-05	0.000238	CcSEcCtD
Sertraline—Pruritus—Methotrexate—multiple sclerosis	7.61e-05	0.000237	CcSEcCtD
Sertraline—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.57e-05	0.00149	CbGpPWpGaD
Sertraline—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.5e-05	0.00147	CbGpPWpGaD
Sertraline—MAOA—Biological oxidations—POMC—multiple sclerosis	7.48e-05	0.00147	CbGpPWpGaD
Sertraline—Diarrhoea—Methotrexate—multiple sclerosis	7.36e-05	0.000229	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	7.34e-05	0.00144	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	7.33e-05	0.00144	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.28e-05	0.00143	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.26e-05	0.00143	CbGpPWpGaD
Sertraline—Dizziness—Methotrexate—multiple sclerosis	7.11e-05	0.000221	CcSEcCtD
Sertraline—MAOB—Metabolism—RRM1—multiple sclerosis	6.87e-05	0.00135	CbGpPWpGaD
Sertraline—Vomiting—Methotrexate—multiple sclerosis	6.84e-05	0.000213	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—CD80—multiple sclerosis	6.78e-05	0.00133	CbGpPWpGaD
Sertraline—Rash—Methotrexate—multiple sclerosis	6.78e-05	0.000211	CcSEcCtD
Sertraline—Dermatitis—Methotrexate—multiple sclerosis	6.77e-05	0.000211	CcSEcCtD
Sertraline—Headache—Methotrexate—multiple sclerosis	6.74e-05	0.00021	CcSEcCtD
Sertraline—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.67e-05	0.00131	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	6.6e-05	0.0013	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.43e-05	0.00126	CbGpPWpGaD
Sertraline—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.41e-05	0.00126	CbGpPWpGaD
Sertraline—Nausea—Methotrexate—multiple sclerosis	6.39e-05	0.000199	CcSEcCtD
Sertraline—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.13e-05	0.00121	CbGpPWpGaD
Sertraline—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.08e-05	0.00119	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.05e-05	0.00119	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.05e-05	0.00119	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.04e-05	0.00119	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	6e-05	0.00118	CbGpPWpGaD
Sertraline—SLC6A4—NRF2 pathway—TGFB1—multiple sclerosis	6e-05	0.00118	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	5.88e-05	0.00116	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	5.87e-05	0.00115	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	5.86e-05	0.00115	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CYP24A1—multiple sclerosis	5.69e-05	0.00112	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CYP27B1—multiple sclerosis	5.69e-05	0.00112	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.51e-05	0.00108	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.51e-05	0.00108	CbGpPWpGaD
Sertraline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	5.46e-05	0.00107	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	5.36e-05	0.00105	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—TNF—multiple sclerosis	5.32e-05	0.00104	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GPC5—multiple sclerosis	5.2e-05	0.00102	CbGpPWpGaD
Sertraline—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.2e-05	0.00102	CbGpPWpGaD
Sertraline—SLC6A2—NRF2 pathway—TGFB1—multiple sclerosis	5.16e-05	0.00101	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.14e-05	0.00101	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—SRM—multiple sclerosis	5.06e-05	0.000994	CbGpPWpGaD
Sertraline—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.95e-05	0.000972	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	4.78e-05	0.00094	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL2—multiple sclerosis	4.76e-05	0.000936	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.71e-05	0.000926	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.71e-05	0.000926	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.71e-05	0.000926	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—POMC—multiple sclerosis	4.69e-05	0.000921	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.58e-05	0.000901	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.57e-05	0.000899	CbGpPWpGaD
Sertraline—SLC6A3—NRF2 pathway—TGFB1—multiple sclerosis	4.57e-05	0.000899	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.57e-05	0.000898	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.56e-05	0.000895	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.48e-05	0.000881	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.36e-05	0.000856	CbGpPWpGaD
Sertraline—MAOA—Metabolism—RRM1—multiple sclerosis	4.31e-05	0.000847	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.29e-05	0.000843	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.27e-05	0.000839	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.27e-05	0.000839	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.03e-05	0.000792	CbGpPWpGaD
Sertraline—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.01e-05	0.000788	CbGpPWpGaD
Sertraline—MAOB—Metabolism—BCHE—multiple sclerosis	3.95e-05	0.000776	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—SRM—multiple sclerosis	3.82e-05	0.000751	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.75e-05	0.000737	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—SRM—multiple sclerosis	3.73e-05	0.000733	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.72e-05	0.00073	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.62e-05	0.000711	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	3.56e-05	0.0007	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	3.56e-05	0.0007	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.54e-05	0.000696	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.52e-05	0.000691	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—SRM—multiple sclerosis	3.52e-05	0.000691	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—IL6—multiple sclerosis	3.5e-05	0.000688	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.49e-05	0.000685	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—SRM—multiple sclerosis	3.49e-05	0.000685	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.47e-05	0.000682	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GPC5—multiple sclerosis	3.26e-05	0.000641	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—POMC—multiple sclerosis	3.26e-05	0.00064	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.23e-05	0.000635	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.2e-05	0.000628	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—SRM—multiple sclerosis	2.98e-05	0.000585	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—MAPK1—multiple sclerosis	2.87e-05	0.000565	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.76e-05	0.000542	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—RRM1—multiple sclerosis	2.7e-05	0.000531	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.69e-05	0.000529	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.69e-05	0.000529	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—MAPK1—multiple sclerosis	2.67e-05	0.000525	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.63e-05	0.000517	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.63e-05	0.000517	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.63e-05	0.000517	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.61e-05	0.000514	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.48e-05	0.000487	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.48e-05	0.000487	CbGpPWpGaD
Sertraline—MAOA—Metabolism—BCHE—multiple sclerosis	2.48e-05	0.000487	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.46e-05	0.000484	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.46e-05	0.000483	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.46e-05	0.000483	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GPC5—multiple sclerosis	2.4e-05	0.000472	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.4e-05	0.000472	CbGpPWpGaD
Sertraline—MAOB—Metabolism—APOE—multiple sclerosis	2.37e-05	0.000467	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.32e-05	0.000455	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—SRM—multiple sclerosis	2.3e-05	0.000452	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.27e-05	0.000445	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.25e-05	0.000441	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.13e-05	0.000419	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.1e-05	0.000412	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.1e-05	0.000412	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.05e-05	0.000403	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.04e-05	0.000401	CbGpPWpGaD
Sertraline—MAOB—Metabolism—POMC—multiple sclerosis	2.04e-05	0.000401	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—RRM1—multiple sclerosis	1.99e-05	0.000391	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.92e-05	0.000377	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.88e-05	0.000369	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.86e-05	0.000366	CbGpPWpGaD
Sertraline—MAOB—Metabolism—ALB—multiple sclerosis	1.86e-05	0.000365	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.84e-05	0.000361	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.83e-05	0.00036	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.8e-05	0.000353	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.71e-05	0.000336	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.62e-05	0.000318	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.62e-05	0.000318	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.59e-05	0.000312	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.58e-05	0.000311	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.55e-05	0.000305	CbGpPWpGaD
Sertraline—MAOA—Metabolism—APOE—multiple sclerosis	1.49e-05	0.000293	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.48e-05	0.000291	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.44e-05	0.000284	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.36e-05	0.000267	CbGpPWpGaD
Sertraline—MAOA—Metabolism—POMC—multiple sclerosis	1.28e-05	0.000251	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.24e-05	0.000244	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.24e-05	0.000244	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.23e-05	0.000242	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.23e-05	0.000241	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.17e-05	0.00023	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ALB—multiple sclerosis	1.17e-05	0.000229	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.15e-05	0.000226	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—BCHE—multiple sclerosis	1.14e-05	0.000225	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.13e-05	0.000222	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.08e-05	0.000212	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.07e-05	0.00021	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.06e-05	0.000208	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.66e-06	0.00019	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—APOE—multiple sclerosis	9.33e-06	0.000183	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.13e-06	0.000179	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—POMC—multiple sclerosis	8.02e-06	0.000158	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ALB—multiple sclerosis	7.31e-06	0.000144	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—APOE—multiple sclerosis	7.05e-06	0.000139	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.05e-06	0.000139	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—APOE—multiple sclerosis	6.88e-06	0.000135	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—APOE—multiple sclerosis	6.49e-06	0.000127	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—APOE—multiple sclerosis	6.43e-06	0.000126	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—POMC—multiple sclerosis	6.06e-06	0.000119	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—POMC—multiple sclerosis	5.91e-06	0.000116	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—POMC—multiple sclerosis	5.57e-06	0.000109	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—POMC—multiple sclerosis	5.52e-06	0.000109	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ALB—multiple sclerosis	5.52e-06	0.000109	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—APOE—multiple sclerosis	5.49e-06	0.000108	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ALB—multiple sclerosis	5.39e-06	0.000106	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ALB—multiple sclerosis	5.08e-06	9.98e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ALB—multiple sclerosis	5.04e-06	9.9e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—POMC—multiple sclerosis	4.72e-06	9.28e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ALB—multiple sclerosis	4.3e-06	8.46e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—APOE—multiple sclerosis	4.24e-06	8.33e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—POMC—multiple sclerosis	3.64e-06	7.16e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ALB—multiple sclerosis	3.32e-06	6.53e-05	CbGpPWpGaD
